Yüklüyor......
Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
During the last decades, further knowledge of hepatocellular carcinoma (HCC) molecular mechanisms has led to development of effective systemic treatments including tyrosine kinase inhibitors (TKIs) and immunotherapy. In this review, we describe first and second line systemic treatment options for ad...
Kaydedildi:
| Yayımlandı: | World J Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201145/ https://ncbi.nlm.nih.gov/pubmed/32390700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i16.1888 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|